Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (55)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kamibayashi, Y.
Right arrow Articles by Oyamada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamibayashi, Y.
Right arrow Articles by Oyamada, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo

Yoshihito Kamibayashi 1 2, Yumiko Oyamada 1, Michio Mori 1 and Masahito Oyamada 1 3

1Departments of Pathology, Sapporo Medical University School of Medicine South-1, West-17, Chuo-ku, Sapporo 060, Japan
2Departments of Plastic and Reconstructive Surgery, Sapporo Medical University School of Medicine South-1, West-17, Chuo-ku, Sapporo 060, Japan

3To whom correspondence should be addressed

To elucidate what changes in the expression of gap junction proteins (connexins) occur at what stages during multistage mouse skin carcinogenesis in vivo, we immunohistochemically and morphometrically analyzed the expression of connexin 26 (Cx26) and connexin 43 (Cx43) in papillomas, well-, moderately- and poorly-differentiated squamous cell carcinomas, as well as in squamous cell carcinomas at invasion sites and those metastasized into lymph nodes in female CD-I mice as a result of treatment with dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate. In papillomas, no clear reduction of the two connexins was observed; however, Cx26 and Cx43 were frequently co-localized in the same gap junction plaques, whereas the two kinds of Cxs were differentially expressed in normal and surrounding non-tumorous epidermis. In squamous cell carcinomas, the expression of both Cx26 and Cx43 significantly decreased compared with surrounding non-tumorous epidermis and papillomas. The Western blot analysis confirmed that both Cx26 and Cx43 proteins were reduced in squamous cell carcinomas compared with papillomas. Furthermore, the expression of Cx26 was reduced as cancer cells became morphologically less differentiated, while that of Cx43 did not change. Squamous cell carcinomas at invasive sites showed clear reduction of Cx26 and Cx43. In squamous cell carcinomas metastasized into lymph nodes, Cx26 was expressed, but few carcinoma cells expressed Cx43. The localization of E-cadherin on the plasma membrane between cancer cells was maintained even at invasive and metastatic sites. Our data suggest that quantitative and qualitative changes in connexin expression are associated with tumor progression, including the loss of differentiation, and invasion and metastasis, during multistage mouse skin carcinogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
S. Langlois, K. N. Cowan, Q. Shao, B. J. Cowan, and D. W. Laird
Caveolin-1 and -2 Interact with Connexin43 and Regulate Gap Junctional Intercellular Communication in Keratinocytes
Mol. Biol. Cell, March 1, 2008; 19(3): 912 - 928.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. El Emir, U. Qureshi, J. L.J. Dearling, G. M. Boxer, I. Clatworthy, A. A. Folarin, M. P. Robson, S. Nagl, M. A. Konerding, and R. B. Pedley
Predicting Response to Radioimmunotherapy from the Tumor Microenvironment of Colorectal Carcinomas
Cancer Res., December 15, 2007; 67(24): 11896 - 11905.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Kalra, Q. Shao, H. Qin, T. Thomas, M. A. Alaoui-Jamali, and D. W. Laird
Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism
Carcinogenesis, December 1, 2006; 27(12): 2528 - 2537.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
L Kanczuga-Koda, S Sulkowski, A Lenczewski, M Koda, A Wincewicz, M Baltaziak, and M Sulkowska
Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.
J. Clin. Pathol., April 1, 2006; 59(4): 429 - 433.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
L. N. Torres, J. M. Matera, C. H. Vasconcellos, J. L. Avanzo, F. J. Hernandez-Blazquez, and M. L. Z. Dagli
Expression of Connexins 26 and 43 in Canine Hyperplastic and Neoplastic Mammary Glands
Vet. Pathol., September 1, 2005; 42(5): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Nishimura, T. Saito, H. Yamasaki, and R. Kudo
Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells
Carcinogenesis, October 1, 2003; 24(10): 1615 - 1623.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-T. Chen, Y.-W. Cheng, M.-C. Chou, T. Sen-Lin, W.-W. Lai, W. L. Ho, and H. Lee
The Correlation between Aberrant Connexin 43 mRNA Expression Induced by Promoter Methylation and Nodal Micrometastasis in Non-Small Cell Lung Cancer
Clin. Cancer Res., September 15, 2003; 9(11): 4200 - 4204.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B Risek, A Pozzi, and N. Gilula
Modulation of gap junction expression during transient hyperplasia of rat epidermis
J. Cell Sci., January 5, 1998; 111(10): 1395 - 1404.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.